Akero Therapeutics develops medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
OaCP (Oncology and Cytogenetic Products) is a company that provides oncology diagnostics laboratories and research institutions with FISH (fluorescence in situ hybridization) solutions.
San Francisco, US HQ
South San Francisco, US
Cork, IE HQ